← Back to Search

Other

PRP Therapy for Alopecia After Breast Cancer Treatment

Phase < 1
Waitlist Available
Led By Anthony M Rossi, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a clinical diagnosis of endocrine therapy induced alopecia (EIA) for breast cancer:
Ludwig stage 1-3 for women
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks from baseline
Awards & highlights

Study Summary

This trial is testing a treatment for hair loss that involves injecting platelets from a person's own blood into their scalp.

Who is the study for?
This trial is for women over 18 with hair loss after breast cancer treatment, who haven't used endocrine therapy in the last 6 months or certain alopecia treatments without a 3-month break. It's not for those pregnant, breastfeeding, with scalp conditions, past hair transplants, taking anticoagulants (unless stopped a week before), or on fish oil/NSAIDs without pausing them.Check my eligibility
What is being tested?
The study tests PRP treatment where participants' own platelets are injected into their scalp to treat hair loss caused by cancer therapy. The process involves blood collection and platelet separation every four weeks for three months.See study design
What are the potential side effects?
Potential side effects may include discomfort at injection sites, bleeding, infection risk at the treated area of the scalp, headache or temporary changes in sensation around the treated areas.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have hair loss due to hormone therapy for breast cancer.
Select...
I am a woman with Ludwig stage 1-3 hair loss.
Select...
I stopped using minoxidil or spironolactone for hair loss 3 months ago.
Select...
I am taking or have taken drugs like tamoxifen for hormone therapy.
Select...
I am taking or have taken aromatase inhibitors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hair Density

Trial Design

1Treatment groups
Experimental Treatment
Group I: Female Breast Cancer PtsExperimental Treatment1 Intervention
Participants include female breast cancer patients who either receive endocrine therapy and suffer from endocrine induced alopecia or suffer from post chemotherapy induced alopecia.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,934 Previous Clinical Trials
588,780 Total Patients Enrolled
2 Trials studying Alopecia
606 Patients Enrolled for Alopecia
Anthony M Rossi, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Media Library

Alopecia Clinical Trial 2023: PRP Treatment Highlights & Side Effects. Trial Name: NCT04459650 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial open to individuals aged 45 or more?

"The criteria for participation in this research necessitates that the age of patients falls between 18 years old and 60."

Answered by AI

Who is eligible to take part in the research project?

"This trial is recruiting thirty individuals with alopecia between 18 and 60 years old who have had incomplete or no regrowth of hair three months after chemotherapy, without any endocrine cancer-related therapy in the past six months. Additionally, patients must meet other criteria such as Ludwig stage 1-3 for female participants, a history of using topical minoxidil and/or systemic spironolactone for at least 3 consecutive months (requiring a washout period prior to treatment) and completion of an informed consent form."

Answered by AI

Are there any vacancies available for this scientific experiment?

"The information on clinicaltrials.gov reveals that this research is not currently recruiting patients, with the initial post being published in June 2020 and last updated March 2022. However, there are 86 other ongoing medical studies actively seeking participants at present."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
New York
What site did they apply to?
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
2
3+

Why did patients apply to this trial?

I've tried over the counter drugs that didn't work, I am hoping this medical trial can help me.
PatientReceived 1 prior treatment
I saw two dermatologists who prescribed medicines that did not work. I have chemo induced alopecia. I also have Graft-Versus-Host Disease which has caused inflammation in my body and a chronic case of ocular GVHD in my eyes. I saw nineteen doctors to treat my eyes that are suffering due to this condition and had a year of failed fittings for scleral lenses. I just cannot afford to undergo non-surgical treatments for my scalp because my vision is the most important thing to me now. I also have trichiasis which causes my lashes to grow in my eyes. I will not give up however, since I already survived two rounds of aplastic anemia and MDS (blood cancer). I really just want my hair back and my life back so I thought I would look into a clinical trial.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

When can I start?
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer
2020. "A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04459650.
All > Androgenetic Alopecia > Alopecia Areata
~1 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top